$DVAX
DYNAVAX TECHNOLOGIES CORP

2012 Q4 Form 10-Q Financial Statement

#000119312512449161 Filed on November 02, 2012

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q3 2011 Q3
Revenue $1.806M $2.874M $1.174M
YoY Change -84.2% 144.8% -89.92%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.290M $7.120M $4.220M
YoY Change 104.18% 68.72% 6.84%
% of Gross Profit
Research & Development $12.52M $12.85M $11.78M
YoY Change 7.75% 9.11% -17.06%
% of Gross Profit
Depreciation & Amortization $310.0K $310.0K $310.0K
YoY Change 6.9% 0.0% -47.46%
% of Gross Profit
Operating Expenses $21.81M $12.85M $11.78M
YoY Change 34.96% 9.11% -35.99%
Operating Profit -$17.10M -$14.82M
YoY Change 15.36%
Interest Expense -$500.0K $589.0K $485.0K
YoY Change 6.38% 21.44% -224.36%
% of Operating Profit
Other Income/Expense, Net -$40.00K -$196.0K $58.00K
YoY Change -104.3% -437.93% -97.29%
Pretax Income -$20.54M -$17.79M -$15.23M
YoY Change 381.03% 16.81% 204.6%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$20.54M -$17.79M -$15.23M
YoY Change 381.44% 16.82% 204.58%
Net Earnings / Revenue -1137.49% -619.03% -1297.19%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.137M -$1.000M -$1.227M
COMMON SHARES
Basic Shares Outstanding 178.7M shares 177.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q4 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $125.1M $148.3M $53.20M
YoY Change 9.74% 178.76% 12.71%
Cash & Equivalents $7.599M $24.65M $19.07M
Short-Term Investments $117.5M $123.6M $34.10M
Other Short-Term Assets $2.100M $2.400M $1.400M
YoY Change 90.91% 71.43% -22.22%
Inventory
Prepaid Expenses
Receivables $1.005M $3.685M $800.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $128.2M $154.4M $55.40M
YoY Change 2.86% 178.67% 10.36%
LONG-TERM ASSETS
Property, Plant & Equipment $7.965M $6.948M $6.100M
YoY Change 29.24% 13.9% -7.58%
Goodwill $2.475M $2.408M
YoY Change 7.05%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $473.0K $438.0K $900.0K
YoY Change 30.66% -51.33% -57.14%
Total Long-Term Assets $11.57M $10.44M $9.300M
YoY Change 21.94% 12.25% -19.83%
TOTAL ASSETS
Total Short-Term Assets $128.2M $154.4M $55.40M
Total Long-Term Assets $11.57M $10.44M $9.300M
Total Assets $139.8M $164.8M $64.70M
YoY Change 4.21% 154.75% 4.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.166M $1.578M $1.300M
YoY Change 6.18% 21.38% -38.1%
Accrued Expenses $10.06M $9.163M $7.300M
YoY Change 23.34% 25.52% -58.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $14.50M $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.01M $29.37M $10.10M
YoY Change -30.14% 190.74% -51.9%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $12.30M
YoY Change -100.0% 17.14%
Other Long-Term Liabilities $629.0K $624.0K $6.100M
YoY Change 1.94% -89.77% -12.86%
Total Long-Term Liabilities $629.0K $624.0K $18.40M
YoY Change 1.94% -96.61% 5.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.01M $29.37M $10.10M
Total Long-Term Liabilities $629.0K $624.0K $18.40M
Total Liabilities $24.93M $34.76M $28.50M
YoY Change -27.16% 21.98% -26.17%
SHAREHOLDERS EQUITY
Retained Earnings -$435.5M -$414.9M
YoY Change 19.14%
Common Stock $183.0K $178.0K
YoY Change 18.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $114.8M $130.1M $36.20M
YoY Change
Total Liabilities & Shareholders Equity $139.8M $164.8M $64.70M
YoY Change 4.21% 154.75% 4.69%

Cashflow Statement

Concept 2012 Q4 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income -$20.54M -$17.79M -$15.23M
YoY Change 381.44% 16.82% 204.58%
Depreciation, Depletion And Amortization $310.0K $310.0K $310.0K
YoY Change 6.9% 0.0% -47.46%
Cash From Operating Activities -$7.590M -$12.35M -$12.71M
YoY Change 43.48% -2.83% 4.35%
INVESTING ACTIVITIES
Capital Expenditures -$1.200M -$330.0K -$160.0K
YoY Change 114.29% 106.25% 77.78%
Acquisitions
YoY Change
Other Investing Activities $5.790M $1.770M -$180.0K
YoY Change -112.02% -1083.33% -101.95%
Cash From Investing Activities $4.590M $1.440M -$340.0K
YoY Change -109.42% -523.53% -103.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -14.18M 930.0K 4.790M
YoY Change -121.15% -80.58% 125.94%
NET CHANGE
Cash From Operating Activities -7.590M -12.35M -12.71M
Cash From Investing Activities 4.590M 1.440M -340.0K
Cash From Financing Activities -14.18M 930.0K 4.790M
Net Change In Cash -17.18M -9.980M -8.260M
YoY Change -231.75% 20.82% 778.72%
FREE CASH FLOW
Cash From Operating Activities -$7.590M -$12.35M -$12.71M
Capital Expenditures -$1.200M -$330.0K -$160.0K
Free Cash Flow -$6.390M -$12.02M -$12.55M
YoY Change 35.1% -4.22% 3.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19072000
CY2012Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2419000
CY2012Q3 us-gaap Goodwill
Goodwill
2408000
CY2012Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
450000
CY2012Q3 us-gaap Notes Payable Current
NotesPayableCurrent
14452000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
6063000 shares
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
438000
CY2012Q3 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
14500000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6729000 shares
CY2012Q3 us-gaap Deferred Rent Credit
DeferredRentCredit
600000
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
130058000
CY2012Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1799000
CY2012Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
148250000
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
11002000
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-968000
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.55
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
178270000 shares
CY2012Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
19000000 shares
CY2012Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1763000
CY2012Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1799000
CY2012Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
123629000
CY2012Q3 us-gaap Liabilities
Liabilities
34764000
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1578000
CY2012Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4172000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14104000
us-gaap Investment Income Interest
InvestmentIncomeInterest
74000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1072000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1403000
us-gaap Interest Expense Other
InterestExpenseOther
1400000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.22
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
624000
CY2012Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1836000
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4417000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
12561000 shares
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-939000
CY2012Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9163000
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
29365000
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
29000
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
178000
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-414948000
CY2012Q3 us-gaap Assets
Assets
164822000
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3685000
CY2012Q3 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
34000
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
164822000
CY2012Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
645000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
20857000
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24650000
CY2012Q3 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
5000
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
178270000 shares
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4775000
CY2012Q3 us-gaap Assets Current
AssetsCurrent
154383000
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
12064000
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6948000
CY2012Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
545767000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.35
CY2012Q3 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
148279000
CY2012Q3 dvax Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
148300000
CY2012Q3 dvax Number Of Trading Days
NumberOfTradingDays
P30D
CY2012Q3 dvax Debt Instrument Issuance Discount Rate
DebtInstrumentIssuanceDiscountRate
0.17 pure
CY2012Q3 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Nonvested Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndNonvestedOptionsOutstandingNumber
15338000 shares
CY2012Q3 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
3.46
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
178707300 shares
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22453000
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1130000
CY2011Q4 us-gaap Goodwill
Goodwill
2312000
CY2011Q4 us-gaap Notes Payable Current
NotesPayableCurrent
12810000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
11524000 shares
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
362000
CY2011Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
600000
us-gaap Revenue From Grants
RevenueFromGrants
2437000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1016000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
24078000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-99000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
8000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44202000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Share Based Compensation
ShareBasedCompensation
3934000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1009000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
99880000
CY2011Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
113964000
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1006000
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154626000 shares
CY2011Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
82020000
CY2011Q4 us-gaap Liabilities
Liabilities
34222000
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2040000
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4210000
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
617000
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-365542000
CY2011Q4 us-gaap Assets
Assets
134102000
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9527000
CY2011Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
9000
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
134102000
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
647000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31941000
CY2011Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
12000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154626000 shares
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1009000
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8159000
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27219000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-3000
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
155000
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
6386000
CY2011Q4 us-gaap Assets Current
AssetsCurrent
124618000
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6163000
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
466276000
CY2011Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
113961000
CY2011Q4 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Nonvested Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndNonvestedOptionsOutstandingNumber
11101000 shares
CY2011Q4 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
3.10
us-gaap Costs And Expenses
CostsAndExpenses
53030000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2997000
us-gaap Operating Income Loss
OperatingIncomeLoss
-42843000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-34000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
169000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41828000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
564000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3381000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13025000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
132000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-218000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
117000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
7000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
128000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39706000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24386000
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1300000
us-gaap Revenues
Revenues
10187000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
38007000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-895000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
119244000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37200000 shares
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
52675000
us-gaap Net Income Loss
NetIncomeLoss
-44330000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-43000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
299000
us-gaap License And Services Revenue
LicenseAndServicesRevenue
652000
us-gaap Interest Expense
InterestExpense
1462000
dvax Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
33000
dvax Supplemental Gains Losses Unrealized Securities
SupplementalGainsLossesUnrealizedSecurities
11000
dvax Collaboration Revenue
CollaborationRevenue
7098000
dvax Increase Decrease In Restricted Cash And Other Assets For Operating Activities
IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities
164000
dvax Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
845000
dei Trading Symbol
TradingSymbol
DVAX
dei Entity Registrant Name
EntityRegistrantName
DYNAVAX TECHNOLOGIES CORP
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001029142
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Costs And Expenses
CostsAndExpenses
55502000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1011000
us-gaap Operating Income Loss
OperatingIncomeLoss
-47594000
us-gaap Revenue From Grants
RevenueFromGrants
3188000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
898000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1789000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1505000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
70000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36631000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
73220000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
412000 shares
us-gaap Share Based Compensation
ShareBasedCompensation
6294000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.69
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-462000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
69619000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y11M27D
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-255000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-6000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-49336000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1815000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y3M7D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.27
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1049000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
36000 shares
CY2012Q3 dvax Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
200000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36217000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44276000
us-gaap Investment Income Interest
InvestmentIncomeInterest
208000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1649000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
115000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.80
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1642000
us-gaap Interest Expense Other
InterestExpenseOther
1600000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1727000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7291000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18871000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
307000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.23
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5842000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
38000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
167039000 shares
us-gaap Net Income Loss
NetIncomeLoss
-49406000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
4094000 shares
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-18000
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
10500000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
412000 shares
us-gaap Revenues
Revenues
7908000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
169634000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-970000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34400000 shares
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
127085000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Use of Estimates</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results may differ from these estimates.</font></p> </div>
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
32000
us-gaap License And Services Revenue
LicenseAndServicesRevenue
1118000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
60000 shares
us-gaap Interest Expense
InterestExpense
1765000
dvax Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
1289000
dvax Supplemental Gains Losses Unrealized Securities
SupplementalGainsLossesUnrealizedSecurities
32000
dvax Collaboration Revenue
CollaborationRevenue
3602000
dvax Issuance Of Common Stock Value For Payment Of Stock Issuance Cost
IssuanceOfCommonStockValueForPaymentOfStockIssuanceCost
1150000
dvax Increase Decrease In Restricted Cash And Other Assets For Operating Activities
IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities
74000
dvax Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
29000
dvax Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
4900000 shares
dvax Share Based Compensation Arrangement By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationTerm
P10Y
CY2009Q4 us-gaap Subordinated Borrowing Due Date
SubordinatedBorrowingDueDate
2012-12-31
CY2012Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
69600000
CY2012Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
17500000 shares
CY2012Q2 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
4.25
CY2011Q3 us-gaap Costs And Expenses
CostsAndExpenses
15994000
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-14820000
CY2011Q3 us-gaap Revenue From Grants
RevenueFromGrants
658000
CY2011Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
58000
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15675000
CY2011Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1287000
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2011Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
18000
CY2011Q3 us-gaap Interest Expense Other
InterestExpenseOther
500000
CY2011Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4217000
CY2011Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-438000
CY2011Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-446000
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11777000
CY2011Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2011Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
400000
CY2011Q3 us-gaap Revenues
Revenues
1174000
CY2011Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
124069000 shares
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-15229000
CY2011Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-8000
CY2011Q3 us-gaap License And Services Revenue
LicenseAndServicesRevenue
147000
CY2011Q3 us-gaap Interest Expense
InterestExpense
485000
CY2011Q3 dvax Collaboration Revenue
CollaborationRevenue
369000
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
19971000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-17097000
CY2012Q3 us-gaap Revenue From Grants
RevenueFromGrants
1219000
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-196000
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17483000
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1903000
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
91000
CY2012Q3 us-gaap Interest Expense Other
InterestExpenseOther
500000
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7121000
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
249000
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
308000
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12850000
CY2012Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2012Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
400000
CY2012Q3 us-gaap Revenues
Revenues
2874000
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
177870000 shares
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-17791000
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
59000
CY2012Q3 us-gaap License And Services Revenue
LicenseAndServicesRevenue
605000
CY2012Q3 us-gaap Interest Expense
InterestExpense
589000
CY2012Q3 dvax Collaboration Revenue
CollaborationRevenue
1050000

Files In Submission

Name View Source Status
0001193125-12-449161-index-headers.html Edgar Link pending
0001193125-12-449161-index.html Edgar Link pending
0001193125-12-449161.txt Edgar Link pending
0001193125-12-449161-xbrl.zip Edgar Link pending
d401615d10q.htm Edgar Link pending
d401615dex1070.htm Edgar Link pending
d401615dex1071.htm Edgar Link pending
d401615dex311.htm Edgar Link pending
d401615dex312.htm Edgar Link pending
d401615dex321.htm Edgar Link pending
d401615dex322.htm Edgar Link pending
dvax-20120930.xml Edgar Link completed
dvax-20120930.xsd Edgar Link pending
dvax-20120930_cal.xml Edgar Link unprocessable
dvax-20120930_def.xml Edgar Link unprocessable
dvax-20120930_lab.xml Edgar Link unprocessable
dvax-20120930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g401615ex10_70pg001a.jpg Edgar Link pending
g401615ex10_70pg002.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending